Mainstays Give And Take As Major Japan Firms Report Results
Xtandi Pressures, Enhertu Prospects
While Daiichi Sankyo reveals ambitious plan with Enhertu, Chugai shows stable growth plans with COVID-19 drugs, Astellas reacted to concerns over Xtandi’s slow growth with enthusiastic investment plan for the next potential star.
